Everolimus-Induced Remission of Classic Kaposi's Sarcoma Secondary to Cryptic Splicing Mediated CTLA4 Haploinsufficiency

J Clin Immunol. 2020 Jul;40(5):774-779. doi: 10.1007/s10875-020-00804-8. Epub 2020 Jun 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Antineoplastic Agents / therapeutic use*
  • CTLA-4 Antigen / genetics*
  • Cellular Reprogramming / drug effects
  • Everolimus / therapeutic use*
  • Haploinsufficiency
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / genetics
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*

Substances

  • Antineoplastic Agents
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Everolimus